Mepolizumab for severe eosinophilic asthma – A one-year real life Portuguese study
Guardado en:
Autores principales: | R Brás, M Paulino, C Varandas, C Coutinho, MI Silva, R Limão, C Costa, E Alonso, E Pedro, A Mendes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier España
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc2a58b7bce240869ec79a542e5789bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mepolizumab and COPD in Real Life
por: Fernando Revuelta-Salgado, et al.
Publicado: (2022) -
A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
por: John Davison, et al.
Publicado: (2021) -
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar P
Publicado: (2017) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021) -
The contribution of an asthma diagnostic consultation service in obtaining an accurate asthma diagnosis for primary care patients: results of a real-life study
por: R. M. E. Gillis, et al.
Publicado: (2017)